Yuefeng Hu

Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines

Jingwei Liu, Shurong Zhang, Yuefeng Hu et al. · Journal of Immunotherapy · 2016 · 126 citations

Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment

Jie Miao, Lu Xu, Yuefeng Hu et al. · Oncotarget · 2017 · 59 citations · Full text

Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model

Yuefeng Hu, Jingwei Liu, Peilin Cui et al. · Cellular Immunology · 2019 · 14 citations · Full text

Synergistic Effect, Tumor Immunology, Cancer Immunosurveillance +10

Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy

Haochen Wang, Weizhong Xiao, Yanjing Han et al. · Journal of Gastrointestinal Oncology · 2022 · 14 citations · Full text

Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellular carcinoma after failed second-line treatment with regorafenib

Haochen Wang, Weizhong Xiao, Yanjing Han et al. · Journal of Gastrointestinal Oncology · 2022 · 10 citations · Full text